Corrigendum: The role of microtubules in pancreatic cancer: therapeutic progress

Mugahed Abdullah Hasan Albahde; Bulat Abdrakhimov; Guo-Qi Li; Xiaohu Zhou; Dongkai Zhou; Hao Xu; Huixiao Qian; Weilin Wang

doi:10.3389/fonc.2024.1414456

Corrigendum: The role of microtubules in pancreatic cancer: therapeutic progress

Front Oncol. 2024 May 1:14:1414456. doi: 10.3389/fonc.2024.1414456. eCollection 2024.

Authors

Mugahed Abdullah Hasan Albahde^#^{1

2

3

4}, Bulat Abdrakhimov^#⁵, Guo-Qi Li^{1

2}, Xiaohu Zhou^{1

2}, Dongkai Zhou^{1

2}, Hao Xu^{1

2}, Huixiao Qian^{1

2}, Weilin Wang^{1

2

3

4

6}

Affiliations

¹ Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
² Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, China.
³ Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Hangzhou, China.
⁴ Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease of Zhejiang University, Hangzhou, China.
⁵ Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
⁶ Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fonc.2021.640863.].

Keywords: drugs; microtubule-targeting agents; microtubules; pancreatic cancer; pancreatic ductal adenocarcinoma.

Publication types

Published Erratum